Article: Chemistry 4.0 in pharmaceutical development
"The pharmaceutical industry is being revolutionised by the utilisation of digital technologies. Chemistry 4.0 describes this digital transformation and how its delivery is paving the way for the industry’s next stage of development."
This article explores the range of digital technologies which are now being employed across the drug development pathway. Our CSO, Gareth Jenkins, and Head of Drug Substance, Paul Quigley, share their insights on Chemistry 4.0 and the digital transformation of the pharmaceutical industry.
You can read the full article here on the TKS Publisher website